PONZ DE LEON, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 40.185
AS - Asia 17.852
EU - Europa 15.994
SA - Sud America 2.521
AF - Africa 322
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 18
Totale 76.920
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 39.781
GB - Regno Unito 7.278
SG - Singapore 6.124
CN - Cina 5.066
HK - Hong Kong 2.053
BR - Brasile 1.964
VN - Vietnam 1.672
SE - Svezia 1.553
DE - Germania 1.435
IT - Italia 1.269
UA - Ucraina 1.093
FI - Finlandia 981
TR - Turchia 875
RU - Federazione Russa 663
FR - Francia 620
KR - Corea 493
BG - Bulgaria 388
IN - India 346
AR - Argentina 202
BD - Bangladesh 196
CA - Canada 181
ID - Indonesia 150
IQ - Iraq 143
MX - Messico 141
NL - Olanda 122
JP - Giappone 114
EC - Ecuador 99
ZA - Sudafrica 96
IE - Irlanda 86
BE - Belgio 83
PK - Pakistan 83
ES - Italia 78
AE - Emirati Arabi Uniti 71
CO - Colombia 65
PL - Polonia 63
CL - Cile 58
VE - Venezuela 58
MY - Malesia 48
UZ - Uzbekistan 45
SA - Arabia Saudita 43
AT - Austria 41
MA - Marocco 39
PH - Filippine 38
NP - Nepal 36
LT - Lituania 33
RO - Romania 33
TN - Tunisia 33
EG - Egitto 32
KE - Kenya 30
DZ - Algeria 29
JO - Giordania 28
TH - Thailandia 28
AZ - Azerbaigian 27
CZ - Repubblica Ceca 26
PY - Paraguay 26
TW - Taiwan 23
AU - Australia 21
IL - Israele 20
PE - Perù 20
OM - Oman 16
CH - Svizzera 15
IR - Iran 15
KZ - Kazakistan 15
PT - Portogallo 14
DO - Repubblica Dominicana 13
JM - Giamaica 13
AL - Albania 12
BO - Bolivia 12
BY - Bielorussia 12
CR - Costa Rica 12
DK - Danimarca 12
UY - Uruguay 12
ET - Etiopia 11
EU - Europa 11
SY - Repubblica araba siriana 11
GE - Georgia 10
GR - Grecia 9
LB - Libano 9
MD - Moldavia 9
PS - Palestinian Territory 9
RS - Serbia 9
PA - Panama 8
HR - Croazia 7
KG - Kirghizistan 7
KW - Kuwait 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
PR - Porto Rico 7
SN - Senegal 7
BA - Bosnia-Erzegovina 6
HU - Ungheria 6
LK - Sri Lanka 6
NG - Nigeria 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BH - Bahrain 5
BZ - Belize 5
EE - Estonia 5
GA - Gabon 5
HN - Honduras 5
MK - Macedonia 5
Totale 76.819
Salva come PNG Salva come JPEG
Città #
Southend 5.521
Singapore 4.102
Fairfield 3.408
Santa Clara 3.216
Ashburn 3.149
Woodbridge 2.650
Jacksonville 2.220
Houston 2.211
Hong Kong 2.033
Chandler 1.835
Hefei 1.744
Dearborn 1.426
Ann Arbor 1.336
Wilmington 1.314
Seattle 1.287
Chicago 1.267
Cambridge 1.115
San Jose 1.067
Beijing 908
Nyköping 895
Los Angeles 881
London 861
Helsinki 579
The Dalles 543
Salt Lake City 542
Ho Chi Minh City 513
Princeton 486
Izmir 463
Seoul 451
Hanoi 406
Sofia 380
Eugene 367
Modena 366
San Diego 356
Lauterbourg 299
Des Moines 289
Council Bluffs 283
New York 271
Elk Grove Village 253
Tampa 238
Moscow 224
Buffalo 215
Dallas 214
Shanghai 190
São Paulo 158
Milan 156
Sterling 138
Columbus 136
Frankfurt am Main 136
Lancaster 125
Bremen 114
Munich 113
Grafing 101
Falls Church 99
Miami 97
Tokyo 92
Orem 91
Da Nang 88
Jakarta 79
Guangzhou 72
Boardman 71
Phoenix 71
Dulles 66
Detroit 65
Atlanta 64
Brussels 62
Haiphong 62
Rio de Janeiro 62
Dublin 61
Norwalk 61
Falkenstein 58
Mexico City 57
Baghdad 56
Fremont 56
Kunming 56
Chennai 55
Nanjing 54
Belo Horizonte 50
Brooklyn 48
Kent 47
Quito 46
Rochester 45
Kansas City 44
Cardiff 42
Denver 42
Dhaka 40
Pittsburgh 40
Tashkent 40
Turku 40
Montreal 39
Jinan 38
Philadelphia 38
Curitiba 36
Nuremberg 36
Porto Alegre 36
Brasília 35
Toronto 35
Chiswick 34
Ottawa 34
Changsha 32
Totale 56.123
Salva come PNG Salva come JPEG
Nome #
Estimates of cancer burden in Italy 698
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 460
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 443
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 439
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 436
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 435
Differentiated Thyroid Carcinoma (DTC) in a Young Woman with Peutz-Jeghers Syndrome: are these Two Conditions Associated? 425
Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. 421
Lymph node micrometastasis and survival of patients with Stage i (Dukes' A) colorectal carcinoma 416
A two-locus model for hereditary non-polyposis colorectal cancer in Modena, Italy 406
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 406
Attenuated polyposis of the large bowel: a morphologic and molecular approach 400
Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry 399
Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life. 398
Cyclooxygenase-2 and Hypoxia-Inducible Factor-1 alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis 394
Morphological and quantitative analysis of BCL6 expression in human colorectal carcinogenesis. 392
K-ras and p53 mutations in human colorectal aberrant crypt foci 390
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 387
Microsatellite instability in multiple colorectal tumors 380
A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability. 379
The influence of age on colonic epithelial cell proliferation 370
Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel 367
Aetiology of colorectal cancer and relevance of monogenic inheritance. 367
Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms. 367
IDENTIFICATION OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER IN THE GENERAL-POPULATION - THE 6-YEAR EXPERIENCE OF A POPULATION-BASED REGISTRY 367
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 364
The cause of colorectal cancer 363
Aberrant crypt foci in patients with colorectal cancer 361
Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome 361
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 358
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 356
An unusual case of familial adenomatous polyposis with very early symptom occurrence 354
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 354
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 349
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors 345
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 337
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 337
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 336
Histology of aberrant crypt foci in the human colon 332
Survival analysis in families affected by hereditary non-polyposis colorectal cancer 332
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 329
Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis. 328
Clinical features and colorectal cancer survival: an attempt to explain differences between two different Italian regions. 326
Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages 325
Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis 319
Small bowel carcinoma in hereditary nonpolyposis colorectal cancer 318
PLZF expression during colorectal cancer development and in normal colorectal mucosa according to body size, as marker of colorectal cancer risk. 317
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 315
Problems in the identification of hereditary nonpolyposis colorectal cancer in two families with late development of full-blown clinical spectrum 314
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 314
Carcinoma papillare e Sindrome di Peutz-Jeghers: una rara associazione 314
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study 312
First observation of microadenomas in the ileal mucosa of patients with familial adenomatous polyposis and colectomies 311
Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature 311
Clinical features of colorectal cancer patients in advanced age: a population-based approach 305
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 304
Decrease in plasma tryptophan after a tryptophan-free amino acid solution. A comparison between cirrhotic and control subjects 302
Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer 301
Cholesterol esterase activity of human intestinal mucosa 296
Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer. 296
Microsatellite instability and colorectal cancer prognosis. 294
Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: A population-based study 292
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 292
Investigation of APC mutations in a Turkish familial adenomatous polyposis family by heterodublex analysis 290
Cancer prevalence in Italian cancer registry areas: The ITAPREVAL study 288
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 287
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis 287
Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome. 285
Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree 283
Infliximab-related hepatitis: discussion of a case and review of the literature. 283
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 282
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary 280
Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. 280
Alteration of drug metabolism during cholestasis in man 277
Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal-cancer registries 275
A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability. 271
Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes 271
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 271
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 270
Colorectal carcinoma in different age groups: A population based investigation 269
The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and women 269
A case of pneumatosis cystoides intestinalis mimicking familial adenomatous polyposis 268
Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: a population-based study 265
Analysis of mismatch repair gene mutations in Turkish HNPCC patients. 265
I tumori in Italia. Rapporto 2011: La sopravvivenza dei pazienti oncologici in Italia 265
Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study 265
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 264
Antioxidant vitamins and colorectal adenoma 263
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 263
Peutz-Jeghers syndrome: a systematic review and recommendations for management 262
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 262
In response. Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability. 260
Effects of acute changes of bile acid pool composition on biliary lipid secretion 258
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 258
Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. 258
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 257
Preventive war and chemoprevention of cancer 257
Biological characterization of mucinous carcinoma of the colon and rectum 256
Incidence trend of malignant polyps through the data of a specialized colorectal cancer registry: clinical features and effect of screening. 254
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: A retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database 251
Totale 32.685
Salva come PNG Salva come JPEG
Categoria #
all - tutte 297.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 297.899
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021634 0 0 0 0 0 0 0 0 0 0 352 282
2021/20225.836 154 907 466 488 134 285 358 273 633 392 1.072 674
2022/20235.088 686 528 321 499 628 951 66 451 608 35 189 126
2023/20243.078 120 211 186 190 799 257 298 435 81 47 98 356
2024/202511.798 445 117 146 870 2.404 1.693 767 654 1.310 708 1.238 1.446
2025/202624.274 1.449 1.011 2.235 3.595 5.892 1.675 2.785 1.323 2.027 1.827 455 0
Totale 77.186